Recombinant Xenopus laevis Oxidoreductase NAD-binding domain-containing protein 1 (oxnad1)

Shipped with Ice Packs
In Stock

Description

Overview

Recombinant Xenopus laevis Oxidoreductase NAD-binding domain-containing protein 1 (OXNAD1) is a protein that, in humans, is encoded by the OXNAD1 gene . It is predicted to have oxidoreductase activity and is located in the mitochondrion .

Basic Information

OXNAD1 is an oxidoreductase NAD-binding domain-containing protein 1 . The protein is produced in Yeast and can be purchased for research purposes .

Gene Information

The OXNAD1 gene encodes a protein with an oxidoreductase NAD-binding domain . The gene is also known as MGC15763 .

Expression

OXNAD1 exhibits general cytoplasmic expression, with additional membranous expression observed in several tissues .

Expression of OXNAD1 mRNA can be influenced by various compounds :

  • Increased expression: Tretinoin, aristolochic acid I, cobaltous chloride, flutamide, nefazodone, nimesulide, perfluorooctanoic acid, pirinixic acid, Soman, triptonide, and valproic acid .

  • Decreased expression: Arsenite, cadmium chloride, clofibrate, copper(II) sulfate, dicrotophos, doxorubicin, epoxiconazole, glycidol, permethrin, quercetin, sodium arsenite .

  • Affected expression: Dibutyl phosphate, paracetamol and triphenyl phosphate .

Function

OXNAD1 is predicted to have oxidoreductase activity .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
oxnad1; Oxidoreductase NAD-binding domain-containing protein 1; EC 1.-.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
19-314
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
oxnad1
Target Protein Sequence
TF PTQSATLLAR APALCAHTMN RRRMSSSQQT DHLERTANTF RQEIISPAKV CGITNESATV KRVRLAIANR EFTFKAGQWV DFFIPGVPKV GGFSICSSPG LLETEGVLEL AVKYNLHPPA HWIHSQCALG SEVAIRVGGE FCFDPQPSDL PLDLVLIAGG VGINPLFSIL LHVADLHKTR EITGRGFQMG NVKLYYCAKN TGELLFKRNI LDLVNSFPGK VTCSFHVTQQ SSPICRELQP FITEGRITEK DLASYVSTDQ LCYICGPPPM IESMCKQLQS LHLPKERILF EKWW
Uniprot No.

Q&A

What is OXNAD1 and why is it studied in Xenopus laevis models?

OXNAD1 (Oxidoreductase NAD-binding domain-containing protein 1) is a protein involved in oxidative stress response and regulation. In Xenopus laevis, this protein plays a significant role in cellular defense against oxidative stress, a process implicated in various diseases including cancer, neurodegenerative disorders, and cardiovascular conditions .

Xenopus laevis serves as an excellent model organism for OXNAD1 research due to several advantages:

  • The high conservation of developmental signaling programs between Xenopus and mammals

  • The large, easily manipulated embryos that facilitate protein expression studies

  • The well-characterized genomic information of Xenopus laevis, despite its allotetraploid nature (having four sets of chromosomes)

How should recombinant Xenopus laevis OXNAD1 protein be prepared and stored for maximum stability?

The recombinant OXNAD1 protein requires specific handling and storage protocols to maintain its stability and activity:

Preparation:

  • Express in E. coli expression systems (as described for product CSB-EP742471XBE-B)

  • Purify to >85% purity using appropriate chromatographic methods

  • Prior to opening the vial, briefly centrifuge to bring contents to the bottom

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

Storage Recommendations:

  • Add 5-50% glycerol (final concentration) and aliquot for long-term storage

  • Store at -20°C/-80°C (liquid form shelf life: 6 months; lyophilized form: 12 months)

  • For working aliquots, store at 4°C for up to one week

  • Avoid repeated freeze-thaw cycles

What experimental approaches are effective for studying OXNAD1 function in Xenopus models?

Several methodological approaches have proven effective for studying OXNAD1 in Xenopus:

Gene Expression Analysis:

  • RT-qPCR to measure OXNAD1 mRNA levels in different developmental stages

  • Microarray or RNA-seq analysis to identify expression patterns during metamorphosis

Genetic Manipulation:

  • CRISPR/Cas9-mediated gene editing: Using crRNA:tracrRNA approach with guide RNAs designed to target the OXNAD1 gene

  • sgRNA design using tools like CRISPRdirect and CRISPRscan

  • Analysis of genome editing efficiency using decomposition analysis

Protein Analysis:

  • Western blotting using specific antibodies (recommended dilution 1:1000-1:5000)

  • ELISA (recommended dilution 1:2000-1:10000)

Functional Studies:

  • Gene expression knockdown using siRNA to assess effects on cell viability, cell growth, apoptosis, and oxidative stress response

  • Analysis of gene-chemical interactions to understand OXNAD1 regulation

How does OXNAD1 expression change during aging in Xenopus compared to mammalian models?

Research has revealed important insights about OXNAD1's role in aging across species:

Expression Patterns:
OXNAD1 shows significant differential expression with chronological age. Studies comparing young and older individuals revealed:

Species/PopulationExpression Change with AgeStudy MethodSample Size
Asian (Chinese)Significantly downregulatedRNA-seqn=19
CaucasianSignificantly downregulatedMicroarrayn=89
Women (across ethnicities)Significantly downregulatedCombined analysisn=124

These findings suggest OXNAD1 downregulation is a conserved feature of aging across different populations .

Functional Implications:
OXNAD1 appears to play important roles in:

  • Cellular metabolism pathways relevant to aging

  • Oxidative stress response mechanisms

  • Potential biomarker applications for aging assessment

The consistent downregulation of OXNAD1 in aging across diverse populations suggests it could serve as a reliable biomarker for biological aging processes .

What are the challenges in studying OXNAD1 in Xenopus laevis versus Xenopus tropicalis?

Researchers face several important considerations when choosing between these two Xenopus species:

Genomic Complexity:

  • Xenopus laevis is allotetraploid (four sets of chromosomes), complicating genetic studies due to gene duplicates that could mask mutant phenotypes

  • Xenopus tropicalis is diploid, making it more suitable for genetic studies including mutation analysis

Experimental Advantages/Disadvantages:

FeatureX. laevisX. tropicalisImplication for OXNAD1 Research
Genome complexityAllotetraploidDiploidPotentially multiple OXNAD1 copies in X. laevis
Embryo sizeLargerSmallerMore material per X. laevis embryo for biochemical analysis
Generation time~12 months~4 monthsFaster genetic studies in X. tropicalis
Cell-free systemsWell establishedLess reliableBetter for X. laevis protein function studies
Established protocolsExtensiveGrowingMore standardized methods in X. laevis

For comprehensive OXNAD1 studies, researchers might consider using both species complementarily—X. tropicalis for genetic manipulation and X. laevis for biochemical and functional analyses .

How can chemical interactions with OXNAD1 be effectively studied in Xenopus models?

Multiple experimental approaches have been documented for studying chemical interactions with OXNAD1:

Chemical Exposure Methods:
Based on studies of rat OXNAD1 that can be adapted to Xenopus models:

ChemicalEffect on OXNAD1Experimental ApproachReference
17β-estradiolDecreases expressionIn vivo exposure followed by RT-qPCRPMID:32145629
2,3,7,8-tetrachlorodibenzodioxineIncreases expressionIn vivo exposure followed by RT-qPCRPMID:33387578
6-propyl-2-thiouracilDecreases expressionIn vivo exposure followed by RT-qPCRPMID:24780913
All-trans-retinoic acidContext-dependentCo-treatment studiesPMID:36189433

Methodology for Xenopus Models:

  • Expose Xenopus embryos or tadpoles to the chemical of interest at appropriate developmental stages

  • Extract RNA from tissue samples

  • Perform RT-qPCR to quantify OXNAD1 expression changes

  • Compare to appropriate vehicle-treated controls

  • Consider co-exposure studies to investigate interaction effects

What role does OXNAD1 play in oxidative stress response during Xenopus development?

OXNAD1 functions as an oxidoreductase with a NAD-binding domain, suggesting important roles in redox processes:

Developmental Context:

  • Expression patterns across developmental stages can be studied using stage-specific RNA extraction and qPCR

  • Particular attention should be paid to metamorphosis, when significant oxidative stress occurs

  • OXNAD1's role can be examined in the context of tissue remodeling during metamorphosis

Experimental Approaches:

  • Loss-of-function studies: Using CRISPR/Cas9 to target OXNAD1 and assess effects on oxidative stress markers

  • Gain-of-function studies: Overexpressing OXNAD1 to determine protective effects against oxidative stressors

  • Chemical challenge experiments: Exposing embryos to oxidative stressors (H₂O₂, UVB radiation) with and without OXNAD1 manipulation

  • Cellular localization studies: Using tagged recombinant OXNAD1 to determine subcellular localization during stress response

How can researchers reconcile contradictory findings about OXNAD1 expression in different studies?

Researchers studying OXNAD1 may encounter apparently contradictory results across different experimental setups. Several factors could explain these discrepancies:

Methodology Considerations:

  • Different detection methods (RNA-seq, microarray, qPCR) have varying sensitivities

  • Antibody specificities may differ between studies

  • RNA extraction methods can impact gene expression measurements

Biological Variables:

  • Developmental stage specificity: OXNAD1 expression varies significantly across developmental stages

  • Tissue-specific expression: Expression patterns may differ between tissues

  • Sex differences: OXNAD1 regulation may be different in males versus females

  • Environmental conditions: Temperature, pH, and other environmental factors can impact expression

Reconciliation Approach:

  • Carefully document all experimental conditions

  • Use multiple methods to validate findings (e.g., both RNA and protein quantification)

  • Include appropriate controls for developmental stage, sex, and tissue type

  • Consider the allotetraploid nature of X. laevis when interpreting gene expression data (potential homoeologs)

What are the key experimental controls needed when studying recombinant OXNAD1 function in Xenopus?

Essential Controls for OXNAD1 Studies:

  • Expression Controls:

    • Empty vector controls for overexpression studies

    • Non-targeting sgRNA/siRNA controls for knockdown studies

    • Validation of knockdown/overexpression by qPCR and western blot

  • Functional Assays:

    • Inclusion of known oxidative stress markers (e.g., catalase, SOD, GSH levels)

    • Positive controls for inducing oxidative stress (e.g., H₂O₂, paraquat)

    • Negative controls using antioxidants (e.g., N-acetylcysteine)

  • Developmental Controls:

    • Precise staging of embryos using Nieuwkoop and Faber staging system

    • Controls for natural variations in OXNAD1 expression during development

    • Age-matched controls when studying aging effects

  • Technical Controls:

    • Multiple biological replicates (minimum n=5 per condition)

    • Multiple technical replicates for each assay

    • Inclusion of housekeeping genes as references for normalization

What are promising applications of OXNAD1 research in human disease models using Xenopus?

OXNAD1's role in oxidative stress response makes it relevant to several human disease models that can be studied in Xenopus:

Cancer Research:

  • OXNAD1 could be studied in the context of cancer progression models in Xenopus

  • G3BP1, another gene involved in cancer that has been studied in oral squamous cell carcinoma, showed significant effects on cell survival when knocked down - similar approaches could be applied to OXNAD1

  • Mutations in chromosome 3, where human OXNAD1 is located, are associated with various cancer types

Neurodegenerative Disorders:

  • Oxidative stress is a key factor in neurodegenerative diseases

  • Xenopus brain models can be used to study OXNAD1's protective role against neurodegeneration

  • Recombinant rabies virus techniques could be adapted to study OXNAD1 in specific neural circuits

Aging-Related Conditions:

  • Given OXNAD1's differential expression with age, it could be a target for interventions against age-related conditions

  • The role of OXNAD1 in peripheral blood mononuclear cells (PBMCs) aging could be further explored in Xenopus immune system development

Developmental Disorders:

  • OXNAD1's potential role in congenital disorders could be modeled using CRISPR/Cas9 methodologies in Xenopus

  • Its connection to retinoic acid signaling pathways suggests potential implications for developmental abnormalities

How might single-cell approaches advance our understanding of OXNAD1 function in Xenopus tissue systems?

Single-cell technologies offer powerful new approaches to understand OXNAD1 function:

Methodological Advances:

  • scRNA-seq in Xenopus tissues:

    • Can reveal cell-type specific expression patterns of OXNAD1

    • Allows tracking of expression changes during developmental transitions

    • Enables identification of co-expression networks and potential functional partners

  • Single-cell proteomics:

    • Could reveal post-translational modifications of OXNAD1

    • Helps identify cell-specific protein interactions

    • Provides insights into subcellular localization differences between cell types

  • Single-cell ATAC-seq:

    • Reveals chromatin accessibility at the OXNAD1 locus

    • Helps identify potential regulatory elements and transcription factors

    • Can track epigenetic changes during development or in response to stressors

Research Applications:

  • Mapping OXNAD1 expression across all cell types during metamorphosis could reveal previously unknown functions

  • Identifying cell populations most sensitive to OXNAD1 manipulation

  • Tracking real-time changes in OXNAD1 expression following oxidative stress in specific cell types

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.